196 related articles for article (PubMed ID: 24338766)
1. Prognostic value of matrix metalloproteinase-7 expression in patients with non-small cell lung cancer.
Liang Y; Guo S; Zhou Q
Tumour Biol; 2014 Apr; 35(4):3717-24. PubMed ID: 24338766
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of matrix metalloproteinase 9 expression in patients with non-small cell lung cancer.
Peng WJ; Zhang JQ; Wang BX; Pan HF; Lu MM; Wang J
Clin Chim Acta; 2012 Jul; 413(13-14):1121-6. PubMed ID: 22465234
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of matrix metalloproteinase-7 and -9 in NSCLC tumor and stromal cells: correlation with a favorable clinical outcome.
Stenvold H; Donnem T; Andersen S; Al-Saad S; Al-Shibli K; Busund LT; Bremnes RM
Lung Cancer; 2012 Feb; 75(2):235-41. PubMed ID: 21764478
[TBL] [Abstract][Full Text] [Related]
4. Expression of p16 in non-small cell lung cancer and its prognostic significance: a meta-analysis of published literatures.
Tong J; Sun X; Cheng H; Zhao D; Ma J; Zhen Q; Cao Y; Zhu H; Bai J
Lung Cancer; 2011 Nov; 74(2):155-63. PubMed ID: 21621871
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of tissue inhibitor of metalloproteinase-2 expression in patients with non-small cell lung cancer: a systematic review and meta-analysis.
Zhu L; Yu H; Liu SY; Xiao XS; Dong WH; Chen YN; Xu W; Zhu T
PLoS One; 2015; 10(4):e0124230. PubMed ID: 25905787
[TBL] [Abstract][Full Text] [Related]
6. The role of matrix metalloproteinase 2 on the survival of patients with non-small cell lung cancer: a systematic review with meta-analysis.
Qian Q; Wang Q; Zhan P; Peng L; Wei SZ; Shi Y; Song Y
Cancer Invest; 2010 Jul; 28(6):661-9. PubMed ID: 20394501
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of K-RAS mutations in patients with non-small cell lung cancer: a systematic review with meta-analysis.
Meng D; Yuan M; Li X; Chen L; Yang J; Zhao X; Ma W; Xin J
Lung Cancer; 2013 Jul; 81(1):1-10. PubMed ID: 23608713
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of CD44 and CD44v6 expression in patients with non-small cell lung cancer: meta-analysis.
Jiang H; Zhao W; Shao W
Tumour Biol; 2014 Aug; 35(8):7383-9. PubMed ID: 24913707
[TBL] [Abstract][Full Text] [Related]
9. The prognostic value of epigenetic silencing of p16 gene in NSCLC patients: a systematic review and meta-analysis.
Lou-Qian Z; Rong Y; Ming L; Xin Y; Feng J; Lin X
PLoS One; 2013; 8(1):e54970. PubMed ID: 23372805
[TBL] [Abstract][Full Text] [Related]
10. The role of human epidermal growth factor receptor 2 as a prognostic factor in lung cancer: a meta-analysis of published data.
Liu L; Shao X; Gao W; Bai J; Wang R; Huang P; Yin Y; Liu P; Shu Y
J Thorac Oncol; 2010 Dec; 5(12):1922-32. PubMed ID: 21155183
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Significance of EZH2 Expression in Non-Small Cell Lung Cancer: A Meta-analysis.
Wang X; Zhao H; Lv L; Bao L; Wang X; Han S
Sci Rep; 2016 Jan; 6():19239. PubMed ID: 26754405
[TBL] [Abstract][Full Text] [Related]
12. The prognostic value of CSCs biomarker CD133 in NSCLC: a meta-analysis.
Chen E; Zeng Z; Bai B; Zhu J; Song Z
Oncotarget; 2016 Aug; 7(35):56526-56539. PubMed ID: 27489355
[TBL] [Abstract][Full Text] [Related]
13. Expression of survivin and patients survival in non-small cell lung cancer: a meta-analysis of the published studies.
Huang LN; Wang DS; Chen YQ; Zhao CL; Gong BL; Jiang AB; Jia W; Hu FD
Mol Biol Rep; 2013 Feb; 40(2):917-24. PubMed ID: 23065255
[TBL] [Abstract][Full Text] [Related]
14. Asian ethnicity is a favorable prognostic factor for overall survival in non-small cell lung cancer (NSCLC) and is independent of smoking status.
Ou SH; Ziogas A; Zell JA
J Thorac Oncol; 2009 Sep; 4(9):1083-93. PubMed ID: 19652625
[TBL] [Abstract][Full Text] [Related]
15. Prognostic effect of matrix metalloproteinase-9 in patients with resected Non small cell lung cancer.
Lee CY; Shim HS; Lee S; Lee JG; Kim DJ; Chung KY
J Cardiothorac Surg; 2015 Mar; 10():44. PubMed ID: 25888323
[TBL] [Abstract][Full Text] [Related]
16. Increased expression of matrix metalloproteinase-2 (MMP-2) predicts tumour recurrence and unfavourable outcome in non-small cell lung cancer.
Leinonen T; Pirinen R; Böhm J; Johansson R; Kosma VM
Histol Histopathol; 2008 Jun; 23(6):693-700. PubMed ID: 18366007
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of pretreatment prognostic nutritional index in non-small cell lung cancer: A systematic review and meta-analysis.
Hu Y; Shen J; Liu R; Feng Z; Zhang C; Ling L; Chen L
Int J Biol Markers; 2018 Nov; 33(4):372-378. PubMed ID: 30282502
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of vascular endothelial growth factor expression in patients with lung cancer: a systematic review with meta-analysis.
Zhan P; Wang J; Lv XJ; Wang Q; Qiu LX; Lin XQ; Yu LK; Song Y
J Thorac Oncol; 2009 Sep; 4(9):1094-103. PubMed ID: 19687765
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of phospho-Akt in patients with non-small cell lung carcinoma: a meta-analysis.
Yang Y; Luo J; Zhai X; Fu Z; Tang Z; Liu L; Chen M; Zhu Y
Int J Cancer; 2014 Sep; 135(6):1417-24. PubMed ID: 24523200
[TBL] [Abstract][Full Text] [Related]
20. Expression and clinical significance of matrix metalloproteinase (MMP)-26 protein in non-small cell lung cancer.
Li L; Mei TH; Zhou XD; Zhang XG
Ai Zheng; 2009 Jan; 28(1):60-3. PubMed ID: 19448419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
